Evogene files for IPO worth up to $60 million

18:10 PM | September 24, 2013 | Rebecca Coons

Evogene (Rehovot, Israel), a plant genomics firm in which Monsanto and Bayer hold 8.7% and 4.6% stakes, respectively, announced today that it has filed a registration statement with the United States...